Serum Free Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Media Type (Common Serum Free, Xeno-Free, Chemically Defined, Protein-Free, Others), By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Contract Research Organizations, Others), By company and By Region

Industry : Healthcare
Pages : NA
Published Date : NA

Customization Enquiry

Buy Now

Single User Licence

$4500

Multi-User Licence

$5500

Custom Research Licence

$8000

Summary

Request Sample

Report Description

The global serum free market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include rising prevalence of infectious and chronic diseases, demand for cell therapies for cancer treatment and increase in R&D activities are impelling the growth of the market. Serum-free media are media intended to grow a specific cell type or execute a specific application in the absence of serum. The use of serum-free media (SFM) signifies an essential tool, that enables cell culture to be performed with a defined set of conditions as free as possible of confounding variables. The other factors supporting the market’s growth are, increasing demand for various recombinant proteins and types of culture, expanding patient registry for rare disease, easier downstream processing, growing research & development for development of novel therapeutic drugs, expansion of biopharmaceutical industries and biopharma production, adoption of advanced technology, and rise in research and development activities. Also, the increasing strategic growth such as mergers, collaborations, and acquisitions are strengthening the growth of the market. For instance, in 2019, Sartorius declared the acquisition of a majority stake in cell culture media specialist biological companies.

Rising Prevalence of Infectious and Chronic Diseases

The rising incidences of infectious and chronic diseases such as cardiovascular diseases, diabetes, STD, respiratory infections and nosocomial (hospital-acquired) infections are bolstering the growth of the market, globally. Owing to the lifestyle changes, social behavior, and unhealthy eating choices, people are suffering from these diseases, which propels the growth of the market. According to the World Health Organization’s (WHO), infectious diseases kill around 17 million people a year. Geriatric populations are highly prone to these diseases such as orthopedic diseases, influenza, cardiovascular diseases, tuberculosis, neurological disorders, and nosocomial (hospital-acquired) infections. According to the National Kidney Foundation, one in four women and one in five men aged between 65 to 74 years have chronic kidney disease across the globe. Serum-free media is used in numerous types of suspension and adherent cultures to produce immunological cells such as cytotoxic lymphocytes (CTLs), IL-2, IL-4, and monocytes, which are utilized in production of a variety of vaccines.

Increasing Biopharmaceutical Production with Adoption of Serum-Free Media

The increase in biopharmaceutical production with rise in adoption of serum free media, due to its properties such as lower risks of infectious agents, less contaminant, and lower risk of interfering components, is facilitating the growth of the market. Owing to the rising incidences of various diseases, the demand to treat these diseases are also surging. This is attributed to the high potency of biopharmaceutical, which enables them to be the choice of treatment, thus increasing the biopharmaceutical production. Thus, the expansion of biopharmaceutical industries and rise in the production are augmenting the growth of the market. For Instance, in 2019, the Center for Drug Evaluation and Research approved 48 new drugs in which 28% of them were biologics.

Download Free Sample Report

Market Segmentation

The global serum free market is segmented into media type, end user and company. Based on media type, the market is segmented into common serum free, xeno-free, chemically defined, protein-free, and others. Based on end user, the market is divided into biotechnology & pharmaceutical companies, academic & research organizations, contract research organizations, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising number of research and development and clinical trials programs in the country.

Market Players

Corning Incorporated, Lonza Group AG, Merck KgaA, Sartorius AG, Thermo Fisher Scientific Inc., FUJIFILM Holdings Corporation, PromoCell GmbH, Athena Environmental Sciences, Inc., STEMCELL Technologies Inc., Danaher Corporation, R&D Systems, Inc., Sino Biological, Inc., HiMedia Laboratories, LLC, PAN-Biotech GmbH, and MP Biomedicals, LLC are some of the leading companies operating in the market.

Attribute	Details
Base Year	2021
Historic Data	2017 – 2020
Estimated Year	2022
Forecast Period	2023 – 2027
Quantitative Units	Revenue in USD Million, Volume Units and CAGR for 2017-2021 and 2022-2027
Report coverage	Revenue forecast, Volume forecast company share, competitive landscape, growth factors, and trends
Segments covered	· Media Type · End User · Company
Regional scope	North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa
Country scope	United States; Canada; Mexico; China; India; Japan; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia; South Africa
Key companies profiled	Corning Incorporated, Lonza Group AG, Merck KgaA, Sartorius AG, Thermo Fisher Scientific Inc., FUJIFILM Holdings Corporation, PromoCell GmbH, Athena Environmental Sciences, Inc., STEMCELL Technologies Inc., Danaher Corporation, R&D Systems, Inc., Sino Biological, Inc., HiMedia Laboratories, LLC, PAN-Biotech GmbH, and MP Biomedicals, LLC
Customization scope	10% free report customization with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, global serum free market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

· Serum Free Market, By Media Type:

o Common Serum Free

o Xeno-Free

o Chemically Defined

o Protein-Free

o Others

· Serum Free Market, By End User:

Biotechnology & Pharmaceutical Companies
Academic & Research Organizations
Contract Research Organizations
Others

· Serum Free Market, By Region:

North America

United States
Canada
Mexico

Asia-Pacific

China
India
Japan
Australia
South Korea

Europe & CIS

Germany
France
United Kingdom
Spain
Italy

South America

Brazil
Argentina
Colombia

Middle East & Africa

§ South Africa

§ Saudi Arabia

§ UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Serum Free Market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Serum Free Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Serum Free Media Market

5. Voice of Customer

6. Global Serum Free Media Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Media Type (Common Serum Free, Xeno-Free, Chemically Defined, Protein-Free, Others)

6.2.2. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Contract Research Organizations, Others)

6.2.3. By Company (2021)

6.2.4. By Region

6.3. Market Map

7. North America Serum Free Media Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Media Type

7.2.2. By End User

7.2.3. By Country

7.3. North America: Country Analysis

7.3.1. United States Serum Free Media Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Media Type

7.3.1.2.2. By End User

7.3.2. Canada Serum Free Media Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Media Type

7.3.2.2.2. By End User

7.3.3. Mexico Serum Free Media Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Media Type

7.3.3.2.2. By End User

8. Europe Serum Free Media Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Media Type

8.2.2. By End User

8.2.3. By Country

8.3. Europe: Country Analysis

8.3.1. France Serum Free Media Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Media Type

8.3.1.2.2. By End User

8.3.2. Germany Serum Free Media Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Media Type

8.3.2.2.2. By End User

8.3.3. United Kingdom Serum Free Media Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Media Type

8.3.3.2.2. By End User

8.3.4. Italy Serum Free Media Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Media Type

8.3.4.2.2. By End User

8.3.5. Spain Serum Free Media Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Media Type

8.3.5.2.2. By End User

9. Asia-Pacific Serum Free Media Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Media Type

9.2.2. By End User

9.2.3. By Country

9.3. Asia-Pacific: Country Analysis

9.3.1. China Serum Free Media Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Media Type

9.3.1.2.2. By End User

9.3.2. India Serum Free Media Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Media Type

9.3.2.2.2. By End User

9.3.3. Japan Serum Free Media Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Media Type

9.3.3.2.2. By End User

9.3.4. South Korea Serum Free Media Market Outlook

9.3.4.1. Market Size & Forecast

9.3.4.1.1. By Value

9.3.4.2. Market Share & Forecast

9.3.4.2.1. By Media Type

9.3.4.2.2. By End User

9.3.5. Australia Serum Free Media Market Outlook

9.3.5.1. Market Size & Forecast

9.3.5.1.1. By Value

9.3.5.2. Market Share & Forecast

9.3.5.2.1. By Media Type

9.3.5.2.2. By End User

10. South America Serum Free Media Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Media Type

10.2.2. By End User

10.2.3. By Country

10.3. South America: Country Analysis

10.3.1. Brazil Serum Free Media Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Media Type

10.3.1.2.2. By End User

10.3.2. Argentina Serum Free Media Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Media Type

10.3.2.2.2. By End User

10.3.3. Colombia Serum Free Media Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Media Type

10.3.3.2.2. By End User

11. Middle East and Africa Serum Free Media Market Outlook

11.1. Market Size & Forecast

11.1.1. By Value

11.2. Market Share & Forecast

11.2.1. By Media Type

11.2.2. By End User

11.2.3. By Country

11.3. MEA: Country Analysis

11.3.1. South Africa Serum Free Media Market Outlook

11.3.1.1. Market Size & Forecast

11.3.1.1.1. By Value

11.3.1.2. Market Share & Forecast

11.3.1.2.1. By Media Type

11.3.1.2.2. By End User

11.3.2. Saudi Arabia Serum Free Media Market Outlook

11.3.2.1. Market Size & Forecast

11.3.2.1.1. By Value

11.3.2.2. Market Share & Forecast

11.3.2.2.1. By Media Type

11.3.2.2.2. By End User

11.3.3. UAE Serum Free Media Market Outlook

11.3.3.1. Market Size & Forecast

11.3.3.1.1. By Value

11.3.3.2. Market Share & Forecast

11.3.3.2.1. By Media Type

11.3.3.2.2. By End User

12. Market Dynamics

12.1. Drivers

12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape (Inclusive SWOT Analysis)

14.1. Corning Incorporated

14.2. Lonza Group AG

14.3. Merck KgaA

14.4. Sartorius AG

14.5. Thermo Fisher Scientific Inc.

14.6. FUJIFILM Holdings Corporation

14.7. PromoCell GmbH

14.8. Athena Environmental Sciences, Inc.

14.9. STEMCELL Technologies Inc.

14.10. Danaher Corporation

14.11. R&D Systems, Inc.

14.12. Sino Biological, Inc.

14.13. HiMedia Laboratories, LLC

14.14. PAN-Biotech GmbH

14.15. MP Biomedicals, LLC

15. Strategic Recommendations

Figures and Tables

Frequently asked questions

What are the major drivers for the Global Serum Free Market?

Growing prevalence of infectious and chronic diseases, rising adoption of advanced techniques, and extensive research and development are driving the demand for the global serum free market.

Who are the top players operating in the Global Serum Free Market?

Corning Incorporated, Lonza Group AG, Merck KgaA, Sartorius AG, Thermo Fisher Scientific Inc., FUJIFILM Holdings Corporation, PromoCell GmbH, Athena Environmental Sciences, Inc., STEMCELL Technologies Inc., Danaher Corporation, R&D Systems, Inc., Sino Biological, Inc., HiMedia Laboratories, LLC, PAN-Biotech GmbH, and MP Biomedicals, LLC are the key players operating in the global serum free market.

What are the key factors hampering growth for the Global Serum Free Market?

The requirement of diverse cell-type for specific media formulation, and low growth rate in comparison to serum-supplemented media may hamper the growth of the global serum free market.